ReviewFrontiers in cell and developmental biology2023

Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer.

Peizhen Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.